Panaxia Global

Panaxia Global is a pharmaceutical company specializing in the development, manufacturing, and marketing of medical cannabis products based on clinical data. The company focuses on advanced delivery methods, including sublingual tablets, metered-dose inhalers, and suppositories, to provide standardized and precise dosing for patients. Panaxia operates EU-GMP certified facilities and has a significant presence in international markets such as Germany and Israel. Their research and development efforts target chronic pain, neurological disorders, and palliative care. The company is recognized for bridging the gap between traditional herbal cannabis and pharmaceutical-grade medical treatments.